Wadhane Jitendra bought PYXS
March 26, 2024 · Form 4 insider transaction
Wadhane Jitendra bought 131,484 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
131,484
Price
$0.00
Total value
N/A
InsiderWadhane Jitendra
RoleOfficer
CompanyPyxis Oncology, Inc. (PYXS)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 26, 2024
Filing dateMarch 28, 2024
Shares owned after398,421
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.